http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014094511-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6890b1f2727fc82ce15bcad3cbd7d1ff
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
filingDate 2013-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ead45ec7a8a79f342f0baeb8fc57167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b523dd08d0b2e87d42808ca74529230
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5d260d09e125428f185e19d542524ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6dcd4507b97e6676ba1757866d348ab
publicationDate 2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014094511-A1
titleOfInvention Treatment of Obstructive Sleep Apnea Syndrome with a Combination of a Carbonic Anhydrase Inhibitor and an Additional Active Agent
abstract This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from obstructive sleep apnea syndrome (OSAS). Treatment of OSAS is effected by administering a carbonic anhydrase inhibitor to the patient in combination with at least one additional active agent. Examples of additional active agents include modafinil, eszopiclone, zolpidem, zaleplon, and phentermine.
priorityDate 2010-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128030519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19917616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129262404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128117044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226459521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129228531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129203714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129202881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127590206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128928354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID410467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129504118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128796506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128524972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127515599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129302252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129266124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127808527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128443807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127864827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129978672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129873686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9690109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128339777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID969472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128445970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID597409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129349966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127963474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1986

Total number of triples: 83.